BIO Statement to the Secretary's Advisory Committee on Genetics, Health & Society
<p>
On behalf of BIO's member companies, we appreciate the opportunity to comment on the recently issued public consultation draft report on "Gene Patents and Licensing Practices and Thier Impact on Patient Access to Genetic Tests"</p>